Stock listing
Apogee Therapeutics, Inc.
Selected listing: APGE · NASDAQ · USD · US
Apogee Therapeutics, Inc. (NASDAQ:APGE), Health Technology. Latest release Jun 22, 2026: AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio.
- Ticker
- NASDAQ:APGE
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Apogee Therapeutics, Inc.
The company focuses on developing innovative therapeutic solutions. Apogee is committed to advancing healthcare through its research and development efforts.
Latest news from Apogee Therapeutics, Inc.
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
June 21, 2026
Apogee Therapeutics to Participate in Upcoming June Conferences
May 28, 2026
Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis
May 26, 2026
Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart
May 26, 2026
Apogee Therapeutics to Host Conference Call to Report Part B 16-Week Data from the Phase 2 APEX Trial of Zumilokibart in Patients with Moderate-to-Severe Atopic Dermatitis on May 27, 2026
May 26, 2026
Events
Replays
Apogee Therapeutics, Inc. (APGE) Q1 2026 Earnings Call
Mon, Mar 23, 2026 · 08:00 AM ET
Watch
Research Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc. company profile
View the public company page for Apogee Therapeutics, Inc. on 6ix.
Apogee Therapeutics, Inc. news
Read company news and market updates connected to Apogee Therapeutics, Inc..
Apogee Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Apogee Therapeutics, Inc..